Form 8-K - Current report:
SEC Accession No. 0001104659-25-007610
Filing Date
2025-01-30
Accepted
2025-01-30 16:28:10
Documents
20
Period of Report
2025-01-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm254657d4_8k.htm   iXBRL 8-K 35327
2 EXHIBIT 1.1 tm254657d4_ex1-1.htm EX-1.1 260682
3 EXHIBIT 5.1 tm254657d4_ex5-1.htm EX-5.1 9516
4 EXHIBIT 99.1 tm254657d4_ex99-1.htm EX-99.1 9967
5 EXHIBIT 99.2 tm254657d4_ex99-2.htm EX-99.2 10528
9 GRAPHIC tm254657d4_ex5-1img001.jpg GRAPHIC 3087
10 GRAPHIC tm254657d4_ex99-1img001.jpg GRAPHIC 2703
11 GRAPHIC tm254657d4_ex99-2img001.jpg GRAPHIC 3224
  Complete submission text file 0001104659-25-007610.txt   591032

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA immu-20250129.xsd EX-101.SCH 3015
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20250129_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20250129_pre.xml EX-101.PRE 22359
23 EXTRACTED XBRL INSTANCE DOCUMENT tm254657d4_8k_htm.xml XML 3689
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 25574117
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)